Delivery Order SPE2DB22D1106-SPE2DB25FFDH4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal sprays, valued at $1,043.25. The contract was competitively awarded without set-aside designation on August 26, 2025, with an ultimate completion date of August 27, 2025. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,827.04 to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal sprays under a firm fixed price contract. The award was made on July 24, 2025, with an ultimate completion date of July 25, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,043.25 to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal spray, with an ultimate completion date of September 11, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Nayzilam 5 mg nasal sprays, with a ceiling value of $1,043.25. This is a firm fixed price, competitively awarded contract with no set-aside designation. The delivery order is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. This award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,391.00 to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal spray on August 26, 2025, with completion scheduled for August 27, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $2,177.86 to AmerisourceBergen Drug Corp for Nayzilam 5 mg nasal sprays on August 14, 2025, with ultimate completion by August 15, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside transaction executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Nayzilam 5 mg nasal spray with a contract ceiling value of $5,778.72. This is a firm fixed-price delivery order with an ultimate completion date of September 5, 2025. The contract utilizes no set-aside designation and was awarded competitively. Performance will take place at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,642.12 to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal sprays, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Nayzilam is a rapid-acting benzodiazepine spray used for acute seizure management and represents the type of...
- The Defense Logistics Agency awarded a $3,477.50 delivery order to AmerisourceBergen Drug Corp for Nayzilam 5 mg nasal sprays under a firm fixed price contract structure. The award was issued on July 28, 2025, with a completion date of July 29, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location. This delivery order is executed as a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Nayzilam 5 mg nasal sprays, with a ceiling value of $1,043.25. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor. The order...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFDH4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nayzilam 5 mg nasal sprays, with a ceiling value of $2,371.57 and an ultimate completion date of August 15, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award leverages AmerisourceBergen's established relationship with the federal government as a major pharmaceutical distributor serving military and veteran healthcare systems. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. This comprehensive pharmaceutical support vehicle enables the company to supply medications and medical supplies to support military healthcare programs globally. Nayzilam, a nasal spray formulation of midazolam used for acute seizure management, represents a specialized medical commodity within the broader range of pharmaceutical products the contractor provides through its federal contract portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 8/14/25 |